Back
NovaBay Pharmaceuticals Vs. Digimarc Industry Stock Comparison
Buy
53
NBY
NovaBay Pharmaceuticals
Last Price:
$0.65
Seasonality Move:
15.02%
Buy
69
DMRC
Digimarc
Last Price:
$47.47
Seasonality Move:
-0.46%
Buy
53
NovaBay Pharmaceuticals (NBY)
is a Buy
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals [NBY] share price is $0.64. The Score for NBY is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
NBY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight buying pressure.
DMRC Stock Price Chart
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 60.07 | Buy |
Chaikin Money Flow: | 35742 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.53 - 0.61) | Buy |
Bollinger Bands (100): | (0.51 - 0.69) | Buy |
DMRC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.6 | Buy |
Relative Strength Index (14 RSI): | 78.22 | Buy |
Chaikin Money Flow: | 85595 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.95 - 40.57) | Buy |
Bollinger Bands (100): | (27.05 - 35.65) | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.59 | Buy |
20-day SMA: | 0.57 | Buy |
50-day SMA: | 0.63 | Buy |
200-day SMA: | 1.69 | Sell |
8-day EMA: | 0.6 | Buy |
20-day EMA: | 0.59 | Buy |
50-day EMA: | 0.63 | Buy |
200-day EMA: | 4.35 | Sell |
DMRC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.59 | Buy |
20-day SMA: | 37.98 | Buy |
50-day SMA: | 34.59 | Buy |
200-day SMA: | 29.38 | Buy |
8-day EMA: | 41.69 | Buy |
20-day EMA: | 38.66 | Buy |
50-day EMA: | 35.39 | Buy |
200-day EMA: | 31.4 | Buy |
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.44 per share, and an increase next year of $0.44 per share.
Digimarc Earnings Growth & DMRC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Digimarc Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |